title: Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate.
authors.forename: Jennifer P
authors.initials: JP
authors.lastname: Schneider
mesh_terms: D015502:Absorptiometry, Photon; D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005264:Femoral Fractures / Q000000981:diagnostic imaging / Q000209:etiology*; D005500:Follow-Up Studies; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications* / Q000188:drug therapy; D013997:Time Factors
chemical_list: D050071:Bone Density Conservation Agents; D019386:Alendronate